Marc Daëron
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marc Daëron has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Anna Niarakis
Molecular, Cellular and Developmental Biology Unit (MCD), Centre for Integrative Biology (CBI), University of Toulouse, UPS, CNRS, Toulouse, France, Lifeware Group, Inria, Saclay-Ile-de-France, Palaiseau, France
3 shared publications Yacine Bounab
Institut Pasteur
3 shared publications- Anne-Marie Hesse
Univ. Grenoble Alpes, INSERM, CEA, UA13 BGE, CNRS, CEA, UAR2048, Grenoble 38000, France
2 shared publications - Bernard Malissen
Centre d’Immunologie de Marseille-Luminy, Aix-Marseille Université, INSERM, CNRS, Marseille, France
2 shared publications - Denis Thieffry
Institut Curie, Université PSL, Paris, France
2 shared publications Jérôme Garin
CEA, IRTSV
2 shared publications
Latest Publications
- 1 February 2016
- Published by Elsevier in Current Opinion in Immunology
- Vol. 38, 101-108
Innate myeloid cells under the control of adaptive immunity: the example of mast cells and basophils
- 1 February 2016
- Published by Elsevier in Current Opinion in Immunology
- Vol. 38, 101-108
Innate myeloid cells under the control of adaptive immunity: the example of mast cells and basophils
- 1 January 2016
- Published by Springer Nature
- p. 612-619
Immunoglobulin Receptors and Inflammation
- 20 September 2014
- Published by Springer Nature
- p. 1-10
Activating and Inhibitory Receptors on Mast Cells
- 20 September 2014
- Published by Springer Nature
- p. 1-10
Activating and Inhibitory Receptors on Mast Cells
- 12 August 2014
- Published by Springer Nature
- Vol. 382, 131-164
Fc Receptors as Adaptive Immunoreceptors
Most biological activities of antibodies depend on their ability to engage Receptors for the Fc portion of immunoglobulins (FcRs) on a variety of cell types. As FcRs can trigger positive and negative signals, as these signals control several biological activities in individual cells, as FcRs are expressed by many cells of hematopoietic origin, mostly of the myeloid lineage, as these cells express various combinations of FcRs, and as FcR-expressing cells have different functional repertoires, antibodies can exert a wide spectrum of biological activities. Like B and T Cell Receptors (BCRs and TCRs), FcRs are bona fide immunoreceptors. Unlike BCRs and TCRs, however, FcRs are immunoreceptors with an adaptive specificity for antigen, with an adaptive affinity for antibodies, with an adaptive structure and with an adaptive signaling. They induce adaptive biological responses that depend on their tissue distribution and on FcR-expressing cells that are selected locally by antibodies. They critically determine health and disease. They are thus exquisitely adaptive therapeutic tools.
- 12 August 2014
- Published by Springer Nature
- Vol. 382, 131-164
Fc Receptors as Adaptive Immunoreceptors
Most biological activities of antibodies depend on their ability to engage Receptors for the Fc portion of immunoglobulins (FcRs) on a variety of cell types. As FcRs can trigger positive and negative signals, as these signals control several biological activities in individual cells, as FcRs are expressed by many cells of hematopoietic origin, mostly of the myeloid lineage, as these cells express various combinations of FcRs, and as FcR-expressing cells have different functional repertoires, antibodies can exert a wide spectrum of biological activities. Like B and T Cell Receptors (BCRs and TCRs), FcRs are bona fide immunoreceptors. Unlike BCRs and TCRs, however, FcRs are immunoreceptors with an adaptive specificity for antigen, with an adaptive affinity for antibodies, with an adaptive structure and with an adaptive signaling. They induce adaptive biological responses that depend on their tissue distribution and on FcR-expressing cells that are selected locally by antibodies. They critically determine health and disease. They are thus exquisitely adaptive therapeutic tools.
- 12 August 2014
- Published by Springer Nature
- Vol. 382, 69-93
Computational Modeling of the Main Signaling Pathways Involved in Mast Cell Activation
A global and rigorous understanding of the signaling pathways and cross-regulatory processes involved in mast cell activation requires the integration of published information with novel functional datasets into a comprehensive computational model. Based on an exhaustive curation of the existing literature and using the software CellDesigner, we have built and annotated a comprehensive molecular map for the FcεRI signaling network. This map can be used to visualize and interpret high-throughput expression data. Furthermore, leaning on this map and using the logical modeling software GINsim, we have derived a qualitative dynamical model, which recapitulates the most salient features of mast cell activation. The resulting logical model can be used to explore the dynamical properties of the system and its responses to different stimuli, in normal or mutant conditions.
- 12 August 2014
- Published by Springer Nature
- Vol. 382, 69-93
Computational Modeling of the Main Signaling Pathways Involved in Mast Cell Activation
A global and rigorous understanding of the signaling pathways and cross-regulatory processes involved in mast cell activation requires the integration of published information with novel functional datasets into a comprehensive computational model. Based on an exhaustive curation of the existing literature and using the software CellDesigner, we have built and annotated a comprehensive molecular map for the FcεRI signaling network. This map can be used to visualize and interpret high-throughput expression data. Furthermore, leaning on this map and using the logical modeling software GINsim, we have derived a qualitative dynamical model, which recapitulates the most salient features of mast cell activation. The resulting logical model can be used to explore the dynamical properties of the system and its responses to different stimuli, in normal or mutant conditions.
- Open Access
- 6 May 2014
- Published by Springer Nature in Virology Journal
- Vol. 11 (1) , 1-11
Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
Public health risks associated to infection by human coronaviruses remain considerable and vaccination is a key option for preventing the resurgence of severe acute respiratory syndrome coronavirus (SARS-CoV). We have previously reported that antibodies elicited by a SARS-CoV vaccine candidate based on recombinant, full-length SARS-CoV Spike-protein trimers, trigger infection of immune cell lines. These observations prompted us to investigate the molecular mechanisms and responses to antibody-mediated infection in human macrophages. We have used primary human immune cells to evaluate their susceptibility to infection by SARS-CoV in the presence of anti-Spike antibodies. Fluorescence microscopy and real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) were utilized to assess occurrence and consequences of infection. To gain insight into the underlying molecular mechanism, we performed mutational analysis with a series of truncated and chimeric constructs of fragment crystallizable γ receptors (FcγR), which bind antibody-coated pathogens. We show here that anti-Spike immune serum increased infection of human monocyte-derived macrophages by replication-competent SARS-CoV as well as Spike-pseudotyped lentiviral particles (SARS-CoVpp). Macrophages infected with SARS-CoV, however, did not support productive replication of the virus. Purified anti-viral IgGs, but not other soluble factor(s) from heat-inactivated mouse immune serum, were sufficient to enhance infection. Antibody-mediated infection was dependent on signaling-competent members of the human FcγRII family, which were shown to confer susceptibility to otherwise naïve ST486 cells, as binding of immune complexes to cell surface FcγRII was necessary but not sufficient to trigger antibody-dependent enhancement (ADE) of infection. Furthermore, only FcγRII with intact cytoplasmic signaling domains were competent to sustain ADE of SARS-CoVpp infection, thus providing additional information on the role of downstream signaling by FcγRII. These results demonstrate that human macrophages can be infected by SARS-CoV as a result of IgG-mediated ADE and indicate that this infection route requires signaling pathways activated downstream of binding to FcγRII receptors.
- 6 May 2014
- Published by Springer Nature in Virology Journal
- Vol. 11 (1) , 1-11
Open AccessAntibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
Public health risks associated to infection by human coronaviruses remain considerable and vaccination is a key option for preventing the resurgence of severe acute respiratory syndrome coronavirus (SARS-CoV). We have previously reported that antibodies elicited by a SARS-CoV vaccine candidate based on recombinant, full-length SARS-CoV Spike-protein trimers, trigger infection of immune cell lines. These observations prompted us to investigate the molecular mechanisms and responses to antibody-mediated infection in human macrophages. We have used primary human immune cells to evaluate their susceptibility to infection by SARS-CoV in the presence of anti-Spike antibodies. Fluorescence microscopy and real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) were utilized to assess occurrence and consequences of infection. To gain insight into the underlying molecular mechanism, we performed mutational analysis with a series of truncated and chimeric constructs of fragment crystallizable γ receptors (FcγR), which bind antibody-coated pathogens. We show here that anti-Spike immune serum increased infection of human monocyte-derived macrophages by replication-competent SARS-CoV as well as Spike-pseudotyped lentiviral particles (SARS-CoVpp). Macrophages infected with SARS-CoV, however, did not support productive replication of the virus. Purified anti-viral IgGs, but not other soluble factor(s) from heat-inactivated mouse immune serum, were sufficient to enhance infection. Antibody-mediated infection was dependent on signaling-competent members of the human FcγRII family, which were shown to confer susceptibility to otherwise naïve ST486 cells, as binding of immune complexes to cell surface FcγRII was necessary but not sufficient to trigger antibody-dependent enhancement (ADE) of infection. Furthermore, only FcγRII with intact cytoplasmic signaling domains were competent to sustain ADE of SARS-CoVpp infection, thus providing additional information on the role of downstream signaling by FcγRII. These results demonstrate that human macrophages can be infected by SARS-CoV as a result of IgG-mediated ADE and indicate that this infection route requires signaling pathways activated downstream of binding to FcγRII receptors.
- Open Access
- 1 October 2013
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 12 (10) , 2874-2889
Proteomic Analysis of the SH2Domain-containing Leukocyte Protein of 76 kDa (SLP76) Interactome
- 1 October 2013
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 12 (10) , 2874-2889
Open AccessProteomic Analysis of the SH2Domain-containing Leukocyte Protein of 76 kDa (SLP76) Interactome
- 1 June 2013
- Published by Elsevier in Current Opinion in Immunology
- Vol. 25 (3) , 313-320
Phosphatase regulation of immunoreceptor signaling in T cells, B cells and mast cells
- 1 June 2013
- Published by Elsevier in Current Opinion in Immunology
- Vol. 25 (3) , 313-320
Phosphatase regulation of immunoreceptor signaling in T cells, B cells and mast cells
- 1 January 2013
- Published by Springer Nature
- p. 1-8
Immunoglobulin Receptors and Inflammation
- 1 March 2012
- Published by Elsevier in Immunology Letters
- Vol. 143 (1) , 20-27
The interactions of therapeutic antibodies with Fc receptors
- 1 March 2012
- Published by Elsevier in Immunology Letters
- Vol. 143 (1) , 20-27
The interactions of therapeutic antibodies with Fc receptors